scholarly journals Intestinal parasites co-infection among tuberculosis patients in Ethiopia: a systematic review and meta-analysis

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Ayinalem Alemu ◽  
Zebenay Workneh Bitew ◽  
Teshager Worku
Keyword(s):  
Systematic Review ◽  
Intestinal Parasites ◽  
Meta Analysis ◽  
Tuberculosis Patients

scholarly journals Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis

PLoS ONE ◽  
2021 ◽  
Vol 16 (10) ◽  
pp. e0259006
Author(s):  
Ashutosh Nath Aggarwal ◽  
Ritesh Agarwal ◽  
Sahajal Dhooria ◽  
Kuruswamy Thurai Prasad ◽  
Inderpaul Singh Sehgal ◽  
...  
Keyword(s):  
Systematic Review ◽  
Pulmonary Tuberculosis ◽  
Patient Outcomes ◽  
Meta Analysis ◽  
Severe Disease ◽  
Random Effects Models ◽  
Tuberculosis Patients ◽  
Active Pulmonary Tuberculosis ◽  
Risk Of Mortality ◽  
Related Mortality

Objective The proportion of COVID-19 patients having active pulmonary tuberculosis, and its impact on COVID-19 related patient outcomes, is not clear. We conducted this systematic review to evaluate the proportion of patients with active pulmonary tuberculosis among COVID-19 patients, and to assess if comorbid pulmonary tuberculosis worsens clinical outcomes in these patients. Methods We queried the PubMed and Embase databases for studies providing data on (a) proportion of COVID-19 patients with active pulmonary tuberculosis or (b) severe disease, hospitalization, or mortality among COVID-19 patients with and without active pulmonary tuberculosis. We calculated the proportion of tuberculosis patients, and the relative risk (RR) for each reported outcome of interest. We used random-effects models to summarize our data. Results We retrieved 3,375 citations, and included 43 studies, in our review. The pooled estimate for proportion of active pulmonary tuberculosis was 1.07% (95% CI 0.81%-1.36%). COVID-19 patients with tuberculosis had a higher risk of mortality (summary RR 1.93, 95% CI 1.56–2.39, from 17 studies) and for severe COVID-19 disease (summary RR 1.46, 95% CI 1.05–2.02, from 20 studies), but not for hospitalization (summary RR 1.86, 95% CI 0.91–3.81, from four studies), as compared to COVID-19 patients without tuberculosis. Conclusion Active pulmonary tuberculosis is relatively common among COVID-19 patients and increases the risk of severe COVID-19 and COVID-19-related mortality.

scholarly journals Intestinal parasites in hemodialysis patients from developing countries: A systematic review and meta‐analysis

2019 ◽  
Vol 24 (1) ◽  
pp. 12-21 ◽  
Author(s):  
Ali Taghipour ◽  
Meysam Olfatifar ◽  
Ali Rostami ◽  
Masoud Foroutan ◽  
VeneelaKrishnaRekha Vasigala ◽  
...  
Keyword(s):  
Systematic Review ◽  
Developing Countries ◽  
Intestinal Parasites ◽  
Meta Analysis ◽  
Hemodialysis Patients

scholarly journals Is hypothyroidism rare in multidrug resistance tuberculosis patients on treatment? A systematic review and meta-analysis

PLoS ONE ◽  
2019 ◽  
Vol 14 (6) ◽  
pp. e0218487 ◽  
Author(s):  
Habteyes Hailu Tola ◽  
Kourosh Holakouie-Naieni ◽  
Tadesse Lejisa ◽  
Mohammad Ali Mansournia ◽  
Mehdi Yaseri ◽  
...  
Keyword(s):  
Systematic Review ◽  
Multidrug Resistance ◽  
Meta Analysis ◽  
Tuberculosis Patients

Health system delay in the treatment of tuberculosis patients in Ethiopia: a systematic review and meta-analysis

2021 ◽  
Author(s):  
Kenaw Tegegne ◽  
Fasil Wagnew ◽  
Yihalem Abebe Belay ◽  
Dawit Eyayu ◽  
Daniel Bekele
Keyword(s):  
Systematic Review ◽  
Health System ◽  
Median Time ◽  
Meta Analysis ◽  
A Priori ◽  
Rural Residence ◽  
System Delay ◽  
Tuberculosis Patients ◽  
Delay In Diagnosis ◽  
Health System Delay

Abstract Background: Delay in diagnosis and initiation of effective treatment associated with increase in morbidity, mortality and on-going person-to-person transmission in the community at large. In Ethiopia, several studies have been conducted regarding health system delay among tuberculosis patients. However, studies assessing the health system delay in treatment of tuberculosis patients in Ethiopia had inconsistent and inconclusive findings. Therefore, this systematic review and meta-analysis aimed to determine the pooled median time of the health system delay in the treatment of tuberculosis and its determinants in Ethiopia. Methods: We systematically searched from different databases: Google Scholar, Science Direct, PubMed, Embase, Scopus and Springer link databases for studies published from June 6, 1997 up to December 20, 2020. The quality of the studies was assessed using the Newcastle-Ottawa scale adapted for observational studies. Heterogeneity was evaluated using I squared statistic. We conducted a meta-analysis for the pooled median time of health system delay and its determinants using random-effects model in R version 4.0.3 software(for median estimation) and Stata version 14 (for metan). The pooled estimates with 95% confidence intervals (CI) were presented using forest plots. Results: A total of 14 studies which comprising 6161 patients satisfying a priori set criteria were included. Our meta-analysis showed that, the estimated pooled median time of the health system delay was 15.29(95%CI: 9.94–20.64) days. In the subgroup analysis, studies conducted from 1997 to 2015 the pooled median health system delay was 21.63(95% CI: 14.38-28.88) days, whereas studies conducted after 2015 the pooled median time of 9.33(95% CI: 3.95-14.70) days. Living in rural area (pooled OR: 2.42, 95%CI: 1.16-5.02) was significantly associated with health system delay. Conclusions: In Ethiopia, patients are delayed more-than two weeks in the treatment of tuberculosis. Being from rural residence was more likely to lead prolonged health system delay. Implementing efforts by targeting rural residence may help to shorten the health system delay and important implications for the success of tuberculosis control.

Sign in / Sign up

Export Citation Format

Share Document